Cytotoxic T-lymphocyte antigen 4 gene polymorphisms and susceptibility to acute allograft rejection

Transplantation

Volumn 72, Issue 5, 2001, Pages 935-940

  Slavcheva, Elena ^a   Albanis, Efsevia ^a   Jiao, Qingsheng ^c   Tran, Huong ^b   Bodian, Carol ^a   Knight, Richard ^a   Milford, Edgar ^b   Schiano, Thomas ^a   Tomer, Yaron ^a   Murphy, Barbara ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c Box 1243 ^*

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;

ARTICLE; CYTOTOXIC T LYMPHOCYTE; DINUCLEOTIDE REPEAT; DNA POLYMORPHISM; DOWN REGULATION; EXON; FEMALE; GENE FREQUENCY; GRAFT REJECTION; HUMAN; IMMUNOREGULATION; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; PRIORITY JOURNAL;

EID: 0035884420     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200109150-00032     Document Type: Article

References (42)

1. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4
2. Acquired thymic tolerance: Role of CTLA4 in the initiation and maintenance of tolerance in a clinically relevant autoimmune disease model
3. CTLA-4 and T cell activation
4. CTLA-4 can function as a negative regulator of T cell activation
5. CTLA-4 ligation blocks CD28-dependent T cell activation
6. CD28 costimulation mediates T cell expansion via IL-2-independent and IL-2-dependent regulation of cell cycle progression
7. CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates
8. Immunosuppressive effects of human CTLA4Ig in a non-human primate model of allogeneic pancreatic islet transplantation
9. Dinucleotide repeat polymorphism at the human CTLA4 gene
10. CTLA-4 and CD28 activated lymphocyte molecules are closely related in both mouse and human as to sequence, message expression, gene structure, and chromosomal location
11. No evidence for allelic association of a human CTLA-4 promoter polymorphism with autoimmune thyroid disease in either population-based case-control or family-based studies
12. Genetic and physical mapping of a type 1 diabetes susceptibility gene (IDDM12) to a 100-kb phagemid artificial chromosome clone containing D2S72-CTLA4-D2S105 on chromosome 2q33
13. Insulin-dependent diabetes mellitus (IDDM) is associated with CTLA4 polymorphisms in multiple ethnic groups
14. CTLA-4 gene polymorphism associated with Graves' disease in a Caucasian population
15. Codon 17 polymorphism of the cytotoxic T lymphocyte antigen 4 gene in Hashimoto's thyroiditis and Addison's disease
16. CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus
17. CTLA4 codon 17 dimorphism in patients with rheumatoid arthritis
18. CTLA4 gene haplotypes cannot protect from IDDM in the presence of high-risk HLA-DQ8 or DQ2 alleles in German families
19. Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphism and susceptibility to type 1 autoimmune hepatitis
20. CTLA4 promoter and exon 1 dimorphisms in multiple sclerosis
21. Human DNA polymorphism based on length variations in simple-sequence tandem repeats
22. Liver transplantation in the United States from 1987-1998: Updated from the Pitt-UNOS liver transplant registry
23. The UNOS scientific renal transplant registry
24. Adhesion molecule polymorphism in chronic renal allograft failure
25. Effects of MHC-encoded TAP1 and TAP2 gene polymorphisms and matching on kidney graft rejection
26. Impact of the MHC-encoded HLA-DMA, DMB, and LMP-2 gene polymorphisms on kidney graft outcome
27. TAP1, TAP2, LMP2, DMA, and DMB genetic polymorphisms in renal transplantation
28. HLA-DMA allele polymorphism: No impact on kidney allograft outcome
29. The importance of genetic polymorphisms in renal transplantation
30. Cytokine gene polymorphisms and heart transplant rejection
31. Analysis of polymorphism of the tumor necrosis factor (TNF) gene and promoter and of circulating TNF-alpha levels in heart-transplant patients suffering from severe rejection
32. Cytokine gene polymorphisms predict acute graft rejection following renal transplantation
33. Tumor necrosis factor genetic polymorphisms correlate with infection after liver transplantation
34. The effect of polymorphisms in tumor necrosis factor-α, interleukin-10, and transforming growth factor-β1 genes in acute hepatic allograft rejection
35. Recipient tumor necrosis factor-α and interleukin-10 gene polymorphisms associated with early mortality and acute graft-versus-host disease severity in HLA-matched sibling bone marrow transplants
36. Genotypic variation in the transforming growth factor-β1 gene
37. CA repeat allele polymorphism in the first intron of the human interferon-γ gene is associated with lung allograft fibrosis
38. Microsatellite alterations on human chromosome 11 in in situ and invasive breast cancer: A microdissection microsatellite analysis and correlation with p53, ER (estrogen receptor), and PR (progesterone receptor) protein immunoreactivity
39. CD28/CTLA4 gene region on chromosome 2q33 confers genetic susceptibility to celiac disease: A linkage and family-based association study
40. Molecular linkage of the human CTLA4 and CD28 Ig-superfamily genes in yeast artificial chromosomes
41. Beta-estradiol suppresses T cell-mediated delayed-type hypersensitivity through suppression of antigen-presenting cell function and Th1 induction
42. Estrogen up-regulates Bcl-2 and blocks tolerance induction of naive B cells